DE69105205D1 - Exprimierung in säugetieren der bmp-2 familie. - Google Patents

Exprimierung in säugetieren der bmp-2 familie.

Info

Publication number
DE69105205D1
DE69105205D1 DE69105205T DE69105205T DE69105205D1 DE 69105205 D1 DE69105205 D1 DE 69105205D1 DE 69105205 T DE69105205 T DE 69105205T DE 69105205 T DE69105205 T DE 69105205T DE 69105205 D1 DE69105205 D1 DE 69105205D1
Authority
DE
Germany
Prior art keywords
bmp
expression
mammals
family
construct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69105205T
Other languages
English (en)
Other versions
DE69105205T2 (de
Inventor
R Hammonds
Anthony Mason
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE69105205D1 publication Critical patent/DE69105205D1/de
Application granted granted Critical
Publication of DE69105205T2 publication Critical patent/DE69105205T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69105205T 1990-05-24 1991-05-20 Exprimierung in säugetieren der bmp-2 familie. Expired - Fee Related DE69105205T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/528,300 US5168050A (en) 1990-05-24 1990-05-24 Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion
PCT/US1991/003540 WO1991018047A2 (en) 1990-05-24 1991-05-20 Mammalian expression of the bmp-2 family

Publications (2)

Publication Number Publication Date
DE69105205D1 true DE69105205D1 (de) 1994-12-22
DE69105205T2 DE69105205T2 (de) 1995-05-18

Family

ID=24105094

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69105205T Expired - Fee Related DE69105205T2 (de) 1990-05-24 1991-05-20 Exprimierung in säugetieren der bmp-2 familie.

Country Status (10)

Country Link
US (1) US5168050A (de)
EP (1) EP0531448B1 (de)
JP (1) JPH05507411A (de)
AT (1) ATE114163T1 (de)
CA (1) CA2082052A1 (de)
DE (1) DE69105205T2 (de)
DK (1) DK0531448T3 (de)
ES (1) ES2067238T3 (de)
GR (1) GR3014924T3 (de)
WO (1) WO1991018047A2 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543394A (en) * 1986-07-01 1996-08-06 Genetics Institute, Inc. Bone morphogenetic protein 5(BMP-5) compositions
US5013649A (en) * 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US5939388A (en) * 1986-07-01 1999-08-17 Rosen; Vicki A. Methods of administering BMP-5 compositions
US5459047A (en) * 1986-07-01 1995-10-17 Genetics Institute, Inc. BMP-6 proteins
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US5284756A (en) * 1988-10-11 1994-02-08 Lynn Grinna Heterodimeric osteogenic factor
US5688678A (en) * 1990-05-16 1997-11-18 Genetics Institute, Inc. DNA encoding and methods for producing BMP-8 proteins
US7378392B1 (en) 1990-05-16 2008-05-27 Genetics Institute, Llc Bone and cartilage inductive proteins
US6395883B1 (en) * 1991-03-11 2002-05-28 Curis, Inc. Soluble morphogenic protein complex compositions of matter
US5290763A (en) * 1991-04-22 1994-03-01 Intermedics Orthopedics/Denver, Inc. Osteoinductive protein mixtures and purification processes
US5693615A (en) * 1991-06-05 1997-12-02 The Procter & Gamble Company Therapeutic compositions for osteoinduction
DK0592562T3 (da) * 1991-06-25 1999-08-30 Genetics Inst BMP-9-præparater
US6287816B1 (en) * 1991-06-25 2001-09-11 Genetics Institute, Inc. BMP-9 compositions
KR100259827B1 (ko) 1991-11-04 2000-06-15 브루스 엠. 에이센, 토마스 제이 데스로저 재조합 골형태 형성 단백질 헤테로다이머, 그 조성물 및 사용방법
DE69333745T2 (de) * 1992-07-31 2005-12-29 Stryker Corp., Kalamazoo Löslicher komplex morphogener proteine und zusammensetzungen davon
KR100227406B1 (ko) * 1993-05-12 1999-12-01 브루스 엠. 에이센 Bmp-11 조성물
US5637480A (en) * 1993-05-12 1997-06-10 Genetics Institute, Inc. DNA molecules encoding bone morphogenetic protein-10
US6291206B1 (en) * 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
AU689184B2 (en) * 1993-12-07 1998-03-26 Genetics Institute, Llc BMP-12, BMP-13 and tendon-inducing compositions thereof
US6027919A (en) * 1993-12-07 2000-02-22 Genetics Institute, Inc. BMP-12 and BMP-13 proteins and DNA encoding them
US5763416A (en) * 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5962427A (en) * 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US6074840A (en) * 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
WO1995024474A1 (en) * 1994-03-10 1995-09-14 Human Genome Sciences, Inc. Bone morphogenic protein-10
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
CA2712304C (en) 1994-06-10 2011-10-25 United States Surgical Corporation Recombinant chimeric proteins and methods of use thereof
US6210899B1 (en) 1994-11-04 2001-04-03 The Procter & Gamble Company Use of a BMP protein receptor complex for screening bone metabolism actives and cells co-transfected with a type II BMP receptor and type I BMP receptor
US5846770A (en) * 1994-11-22 1998-12-08 Genetics Institute, Inc. DNA molecules encoding human chordin
US5645084A (en) * 1995-06-07 1997-07-08 Danek Medical, Inc. Method for spinal fusion without decortication
US5719058A (en) * 1995-04-10 1998-02-17 Merck & Co., Inc. Method for producing a highly enriched population of osteoclast cells
US5635372A (en) * 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
US6927287B1 (en) * 1996-06-03 2005-08-09 United States Surgical Corporation Nucleic acid encoding extracellular matrix protein or fragment thereof
US6492508B1 (en) 1996-06-03 2002-12-10 United States Surgical Corp. A Division Of Tyco Healthcare Group Nucleic acids encoding extracellular matrix proteins
US5965403A (en) * 1996-09-18 1999-10-12 Genetics Institute, Inc. Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
US6034062A (en) * 1997-03-13 2000-03-07 Genetics Institute, Inc. Bone morphogenetic protein (BMP)-9 compositions and their uses
US7057017B2 (en) * 1997-04-16 2006-06-06 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
US6818440B2 (en) * 1997-04-28 2004-11-16 Sugen, Inc. Diagnosis and treatment of alk-7 related disorders
US6228641B1 (en) * 1997-05-20 2001-05-08 Sugen, Inc. Diagnosis and treatment of PTP04 related disorders
DE69840361D1 (de) 1997-07-30 2009-01-29 Univ Emory Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
EP1027076A2 (de) * 1997-10-29 2000-08-16 University Of Pittsburgh Of The Commonwealth System Of Higher Education Verwendung von vektoren wie adenoviren und/oder adeno-assoziierten viren und/oder retroviren und/oder herpes-simplex-viren und/oder liposomen und/oder plasmiden als vehikel für genetische information zur befähigung von säugetierzellen mittel, zur behandlung von knochenpathologien zu produzieren
US7446181B2 (en) * 1998-01-15 2008-11-04 Millennium Pharmaceuticals, Inc. Antibodies that bind human Dickkopf-1 proteins
US20050096274A1 (en) * 1998-04-07 2005-05-05 Lough John W. Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis
US6344541B1 (en) * 1998-09-25 2002-02-05 Amgen Inc. DKR polypeptides
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
DE19906096A1 (de) 1999-02-13 2000-08-17 Walter Sebald Protein mit einem Heparin-bindenden Epitop
CA2386408A1 (en) 1999-10-15 2001-04-26 Genetics Institute, Inc. Formulations of hyaluronic acid for delivery of osteogenic proteins
EP1399023B1 (de) 2001-06-01 2008-04-30 Wyeth Zusammensetzungen für die systemische verabreichung von sequenzen, die für knochenmorphogenese-proteinen kodieren
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
KR20030085337A (ko) * 2002-04-30 2003-11-05 주식회사 서린바이오사이언스 인간 유래의 ｂｍｐ-2 단백질 발현벡터 및 이를 이용한ｂｍｐ-2 대량 생산방법
US20040023322A1 (en) * 2002-08-01 2004-02-05 Goodheart Clyde R. Method of producing non-recombinant BMP-2 and use thereof
EP2292762A3 (de) 2002-12-20 2012-12-12 Board of Regents, The University of Texas System VMP-artige Sequenzen von krankheitserregenden Borrelienspezies und -stämmen
PL1675608T3 (pl) 2003-09-12 2007-11-30 Wyeth Corp Stałe fosforanowo wapniowe pałeczki do wstrzyknięć dla dostarczania białek osteogennych
WO2005041857A2 (en) * 2003-10-07 2005-05-12 Quark Biotech, Inc. Bone morphogenetic protein (bmp) 2a and uses thereof
US20070066525A1 (en) * 2004-02-04 2007-03-22 Lee John C Compositions and therapeutic methods using morphogenic proteins
AU2005267722B2 (en) * 2004-08-04 2009-10-08 Amgen Inc. Antibodies to Dkk-1
US9149543B2 (en) * 2005-12-15 2015-10-06 The Trustees Of The University Of Pennsylvania Methods and models for rapid, widespread delivery of genetic material to the CNS using non-viral, cationic lipid-mediated vectors
US8450107B1 (en) 2011-11-30 2013-05-28 The Broad Institute Inc. Nucleotide-specific recognition sequences for designer TAL effectors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128793A (en) * 1964-11-16 1968-10-02 Eastman Kodak Co Articles
DE2316697A1 (de) * 1972-04-07 1973-10-11 Leer Koninklijke Emballage Durch einwirken von ultravioletter bestrahlung photozersetzbare polymersubstanz
US4495311A (en) * 1972-07-06 1985-01-22 Princeton Polymer Laboratories, Inc. Degradable hydrocarbon polymers
CA1073581A (en) * 1974-01-25 1980-03-11 Canadian Titanium Pigments Ltd. Photodegradable polyolefin material
US5013649A (en) * 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US4877864A (en) * 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
IL83003A (en) * 1986-07-01 1995-07-31 Genetics Inst Factors that soak bone formation
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2

Also Published As

Publication number Publication date
WO1991018047A2 (en) 1991-11-28
WO1991018047A3 (en) 1992-04-02
US5168050A (en) 1992-12-01
EP0531448B1 (de) 1994-11-17
GR3014924T3 (en) 1995-05-31
JPH05507411A (ja) 1993-10-28
ES2067238T3 (es) 1995-03-16
ATE114163T1 (de) 1994-12-15
DK0531448T3 (da) 1995-05-01
EP0531448A1 (de) 1993-03-17
DE69105205T2 (de) 1995-05-18
CA2082052A1 (en) 1991-11-25

Similar Documents

Publication Publication Date Title
DE69105205D1 (de) Exprimierung in säugetieren der bmp-2 familie.
KR880009035A (ko) Apc 폴리펩티드의 전구 단백질, 이를 위한 dna 암호화, 및 이 dna와 단백질의 진단 용도
DK0421635T3 (da) Kimæriske hepadnavirus-kerneantigenproteiner
FI932561A0 (fi) Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellning
DE3677199D1 (de) Herstellung teilfoermiger waschmittelzubereitungen.
ES2056817T5 (es) Transformacion de trichoderma.
IT1142464B (it) Procedimento per il frazionamento di soluzioni di misugli proteici
EA199900869A1 (ru) Цитокин-подобный фактор 7 млекопитающих
DE69102401D1 (de) Verfahren zur Herstellung von kappa-Casein-Glycomakropeptid.
NO169725C (no) Fremgangsmaate for fremstilling av et uglykosylert rekombinant humant immun-interferonprotein
ES2111570T3 (es) Aislamiento y purificacion de la proteina de agente tensioactivo pulmonar.
DK0646176T3 (da) Levering og ekspression af et hybridoverfladeprotein på overfladen af grampositive bakterier
EP0451823A3 (en) Dna constructs for expression of proteins in the lacteal gland of transgenic mammals
DK352888D0 (da) Anordning ved indsproejtningsmekanisme
DE69325836D1 (de) Herstellung von Cis-Olefinen
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
DE68910771D1 (de) Verfahren zur Herstellung von verbessertem Proteinhydrolysat.
FI892985A (fi) Ny polypeptid och anvaendning daerav.
ATE110779T1 (de) Neue promotorregion.
DK563184D0 (da) Olefinsulfonatpraeparater
ATE135015T1 (de) Vasodilatierende und immunsupprimierende peptide
DE69105816D1 (de) Herstellung von Diisopropyläther.
FI944997A0 (fi) Parannettu rekombinantti-proteiinien tuotanto
FI885025A (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
MC1598A1 (fr) Nouveaux vecteurs pour l'expression d'interferon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee